<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR43">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>DÃ­az-Carballo</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Acikelli</surname>
    <given-names>AH</given-names>
   </name>
   <name>
    <surname>Bardenheuer</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Gustmann</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Malak</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Stoll</surname>
    <given-names>R</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma cancer stem cells</article-title>
  <source>Int J Clin Pharmacol Ther</source>
  <year>2014</year>
  <volume>52</volume>
  <issue>9</issue>
  <fpage>787</fpage>
  <lpage>801</lpage>
  <pub-id pub-id-type="doi">10.5414/CP202154</pub-id>
  <?supplied-pmid 24902844?>
  <pub-id pub-id-type="pmid">24902844</pub-id>
 </element-citation>
</ref>
